A modification of the structured clinical interview for DSM-III-R to evaluate methadone patients: Test-retest reliability

American Journal on Addictions

Volumn 5, Issue 3, 1996, Pages 241-248

  Nunes, Edward V ^a   Goehl, Leslie ^a   Seracini, Angela ^a   Deliyannides, Deborah ^a   Donovan, Steven ^a   Koenig, Theresa ^a   Quitkin, Frederic M ^a   Williams, Janet B W ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; INTERVIEW; MALE; METHADONE TREATMENT; MOOD; PANIC; RELIABILITY; SUBSTANCE ABUSE;

EID: 0029759141     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.3109/10550499609041178     Document Type: Article

References (34)

1. Allen MH, Frances RJ: Varieties of psychopathology found in patients with addictive disorders: a review, in Psychopathology and Addictive Disorders. Edited by Meyer RE. New York, Guilford, 1986, pp 17-33
2. Regier DA, Farmer ME, Rae DS, at al: Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 1990; 264:2511-2518
3. Rounsaville BJ, Weissman MM, Crits-Christoph K, et al: Diagnosis and symptoms of depression in opiate addicts: course and relationship to treatment outcome. Arch Gen Psychiatry 1982; 39:151-156
4. Rounsaville BJ, Kosten TR, Weissman MM, et al: Prognostic significance of psychopathology in treated opiate addicts: a 2.5-year follow-up study. Arch Gen Psychiatry 1986; 43:739-745
5. LaPorte DJ, McLellan AT, O'Brien CP, et al: Treatment response in psychiatrically impaired drug abusers. Compr Psychiatry 1981; 22:411-419
6. Kosten TR, Rounsaville BJ, Kleber HD: A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry 1986; 43:733-738
7. Magura S, Siddiqi Q, Freeman RC, et al: Changes in cocaine use after entry to methadone treatment. J Addict Dis 1991; 10:31-15
8. Hatsukami D, Pickens RW: Posttreatment depression in an alcohol and drug abuse population. Am J Psychiatry 1982; 139:1563-1566
9. Nunes EV, Quitkin FM: Treatment of Depression in Drug-Dependent Patients: Effects in Mood and Drug Use. NIDA Research Monographs (in press)
10. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC, American Psychiatric Association, 1994
11. Schuckit MA: Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry 1986; 143:140-147
12. DeLeon G, Skodol A, Rosenthal MS: Phoenix house: changes in psychopathological signs of resident addicts. Arch Gen Psychiatry 1973; 28:131-135
13. Willis JH, Osbourne AB: What happens to heroin addicts? a follow-up study. Br J Addict 1978; 73:189-198
14. Rounsaville BJ, Kosten TR, Kleber HD: Long-term changes in current psychiatric diagnoses of treated opiate addicts. Compr Psychiatry 1986; 27:480-498
15. Pottenger AI, McKernon J, Patrie LE, et al: The frequency and persistence of depressive symptoms in the alcohol abuser. J Nerv Mental Dis 1978; 166:562-570
16. Nakamura MM, Overall JE, Hollister LE, et al: Factors affecting outcome of depressive symptoms in alcoholics. Alcohol Clin Exp Res 1983; 7:188-193
17. Spitzer RL, Williams JBW, Gibbon M, et al: The Structured Clinical Interview for DSM-III-R (SCID), I: history, rationale, and description. Arch Gen Psychiatry 1992; 49:624-629
18. McLellan AT, Luborsky L, Cacciola J, et al: New data from the Addiction Severity Index: reliability and validity in three centers. J Nerv Ment Dis 1985; 173:412-423
19. Stewart JW, McGrath PJ, Quitkin FM, et al: Relevance of DSM-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Arch Gen Psychiatry 1989; 46:1080-1087
20. Fleiss JL: Statistical Methods for Rates and Proportions, 2nd Edition. New York, Wiley, 1981
21. Shrout PE, Fleiss JL: Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86:420-428
22. Robins LN: Epidemiology: reflections on testing the validity of psychiatric interviews. Arch Gen Psychiatry 1985; 42:918-924
23. Williams JBW, Gibbon M, First AIB, et al: The Stuctured Clinical Interview for DSM-III-R (SCID), II: multi-site test-retest reliability. Arch Gen Psychiatry 1992; 49:630-636
24. Ross HE, Swinson R, Doumani S, et al: Diagnosing comorbidity in substance abusers: a comparison of the test-retest reliability of two interviews. Am J Drug Alcohol Abuse 1995; 21:167-185
25. Nunes EV, McGrath PJ, Quitkin FM, et al: Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry 1993; 150:963-965
26. Nunes EV, Quitkin FM, Brady R, et al: Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use. Am J Psychiatry 1991; 148:667-669
27. Bielski RJ, Friedel RO: Prediction of tricyclic antidepressant response. Arch Gen Psychiatry 1976; 33:1479-1489
28. Joyce PR, Paykel ES: Predictors of drug response in depression. Arch Gen Psychiatry 1989; 46:89-99
29. Rounsaville BJ, Anton SF, Carroll K, et al: Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 1991; 48:43-51
30. Johnson J, Weissman MM, Klerman GL: Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 1992; 267:1478-1483
31. Markowitz JS, Weissman MM, Ouellette R, et al: Quality of life in panic disorder. Arch Gen Psychiatry 1989; 46:984-992
32. Noyes R Jr: Suicide and panic disorder: a review. J Affect Disord 1991; 22:1-11
33. Murphy GE, Wetzel RD, Robins E, et al: Multiple risk factors predict suicide in alcoholism. Arch Gen Psychiatry 1992; 49:459-463
34. Levy JC, Deykin EY: Suicidality, depression, and substance abuse in adolescence. Am J Psychiatry 1989; 146:1462-1467